by Team Small News | Jun 14, 2025 | Dr Reddy's
Alvotech, a global biotech company, and Dr. Reddy’s Laboratories, a leading pharmaceutical company, have announced a partnership to develop a biosimilar of Merck’s Keytruda (pembrolizumab) for the treatment of cancer. The partnership aims to bring a more...
by Team Small News | Jun 12, 2025 | Dr Reddy's
A significant theft has been uncovered at Dr. Reddy’s Laboratories, a pharmaceutical company, where eight individuals, including four employees, have been arrested for stealing Semaglutide, an anti-diabetic drug worth over ₹2 crore. The gang attempted to sell...
by Team Small News | Jun 10, 2025 | Dr Reddy's
Alvotech, a global biopharmaceutical company, and Dr. Reddy’s Laboratories, a leading pharmaceutical company, have announced a partnership to develop a biosimilar for the cancer drug Pembrolizumab. Pembrolizumab, marketed under the brand name Keytruda, is a...
by Team Small News | Jun 8, 2025 | Dr Reddy's
Alvotech, a global biotech company based in Iceland, and Dr. Reddy’s Laboratories, an Indian pharmaceutical firm, have entered into a collaboration and license agreement to co-develop, manufacture, and commercialize a biosimilar candidate to Keytruda...
by Team Small News | Jun 7, 2025 | Dr Reddy's
Alvotech, a biopharmaceutical company, and Dr. Reddy’s Laboratories, a pharmaceutical company, have announced a partnership to develop a biosimilar for the cancer drug pembrolizumab. Pembrolizumab is a monoclonal antibody used to treat various types of cancer,...
by Team Small News | Jun 2, 2025 | Dr Reddy's
The Delhi High Court has issued an ad interim injunction to restrain Dr. Reddy’s Laboratories and its distributor, OneSource Pharma, from selling a weight loss drug in India. This decision comes amid a patent dispute with Glenmark Pharmaceuticals, which claims...